In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Decentralised clinical trials and sites: friend or foe?
Emily Mitchell, Executive Director, Decentralised Clinical Trials, contributes to this piece in Clinical Trials Arena on the role of sites in a DCT setting.
-
Due diligence and beyond
Dr. Sandra Eagle outlines how due diligence has evolved from a discrete standalone technical assessment, to now being an integrated part of the holistic development continuum of an asset.
-
LEO Pharma enters clinical trial partnership with ICON
This news article, published on PM Live, highlights how the partnership will advance trial execution within medical dermatology.
-
LEO Pharma and ICON plc collaborate to improve outcomes for dermatology patients
This article, published on Outsourcing Pharma, covers the strategic partnership between LEO Pharma and ICON.
-
The contribution of companies during the Covid-19 pandemic
Rose Kidd, President, Operations Delivery outlines the role ICON played in the search for vaccines and treatments for Covid-19 in the American Chamber of Commerce Ireland 2023 US-Ireland Business Report.
2023 American Chamber of Commerce Ireland
-
LEO Pharma and ICON partner for clinical trial execution in dermatology
This news article, published on Clinical Trials Arena, outlines how the collaboration is expected to provide access to innovative clinical trials as well as help to launch new medicines.
-
LEO Pharma and ICON enter strategic partnership
This news article, first published on Applied Clinical Trials, outlines that LEO Pharma and ICON have announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective.
-
ICON and LEO Pharma join forces on clinical trial mission
This news article, published on PharmaTimes online, indicates how the collaboration will concentrate on launching and running studies within medical dermatology.
-
LEO Pharma, ICON partner to advance clinical trials in dermatology
This news article, first published on Contract Pharma, covers the strategic partnership between LEO Pharma and ICON to propel clinical trial execution within medical dermatology.
-
Strategies for building greater DE&I in Rare Disease trials
This article describes some of the systemic factors that produce barriers at various stages of the rare disease drug development process, as well as identifies strategies to improve diversity in these trials
